Vext Science, Inc. VEXTF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.90M | 12.12M | 12.16M | 13.73M | 12.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.90M | 12.12M | 12.16M | 13.73M | 12.67M |
| Cost of Revenue | 11.85M | 5.41M | 6.64M | 10.40M | 8.70M |
| Gross Profit | 3.05M | 6.71M | 5.52M | 3.33M | 3.97M |
| SG&A Expenses | 4.77M | 4.51M | 4.11M | 6.72M | 3.72M |
| Depreciation & Amortization | 1.76M | 1.41M | 1.41M | -533.00K | 1.66M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.38M | 11.33M | 12.16M | 16.59M | 14.08M |
| Operating Income | -3.48M | 789.00K | 0.00 | -2.86M | -1.41M |
| Income Before Tax | -4.14M | -66.00K | -643.00K | -9.05M | -2.87M |
| Income Tax Expenses | 749.00K | 249.00K | 249.00K | 1.50M | -243.00K |
| Earnings from Continuing Operations | -4.88M | -315.00K | -892.00K | -10.56M | -2.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.88M | -315.00K | -892.00K | -10.56M | -2.63M |
| EBIT | -3.48M | 789.00K | 0.00 | -2.86M | -1.41M |
| EBITDA | -197.00K | 4.55M | 3.73M | 895.00K | 1.91M |
| EPS Basic | -0.02 | 0.00 | 0.00 | -0.04 | -0.01 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | 0.00 | 0.00 | -0.04 | -0.01 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 247.71M | 247.69M | 247.68M | 247.68M | 247.62M |
| Average Diluted Shares Outstanding | 247.71M | 247.69M | 247.68M | 247.68M | 247.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |